Tags Archive Navigation
icon
-
Media ReleaseNovartis Resolves Legacy FCPA Investigations
-
Media ReleaseNovartis Cosentyx® gains positive CHMP opinion for pediatric psoriasis, reinforcing established efficacy and safety profile
-
Media ReleaseNovartis receives positive CHMP opinion for new Xolair® indication to treat severe chronic rhinosinusitis with nasal polyps
-
Media ReleaseNovartis announces MET inhibitor Tabrecta™ approved in Japan for advanced non-small cell lung cancer with METex14
-
Media ReleaseNovartis receives simultaneous approval for five new products from Japanese Ministry of Health, Labour and Welfare, offering Japanese patients a broad range of novel treatment options
-
Media ReleaseNovartis receives EC approval for Enerzair® Breezhaler®, including the first digital companion (sensor and app) that can be prescribed alongside a treatment for uncontrolled asthma in the EU
-
Media ReleaseNovartis resolves legacy litigation matters, finalizing settlement of speaker program litigation with Government in the US and positioning company for the future by fully scaling its next-generation digital engagement technologies
-
Media ReleaseNovartis launches first-of-its-kind not-for-profit portfolio of medicines for symptomatic treatment of COVID-19
-
Media ReleaseNovartis réalise une excellente performance au S1. Prévisions pour 2020 confirmées dans le haut de la fourchette pour le résultat opérationnel core et dans le bas pour le chiffre d’affaires.
-
Media ReleaseNovartis erzielte im ersten Halbjahr eine starke Performance. Die Jahresprognose 2020 für das operative Kernergebnis bzw. den Umsatz wurde am oberen bzw. unteren Ende früherer Voraussagen bestätigt.
-
Media ReleaseNovartis delivered strong H1 performance. FY 2020 guidance confirmed at higher end for core operating income and lower end for sales.
-
Media ReleaseNovartis announces Phase III study of Jakavi® in chronic graft-versus-host disease met primary and key secondary endpoints
Pagination
- ‹ Previous page
- 1
- …
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- › Next page